Cannabidiol clinical trials
Also written CBD, Epidiolex, GWP42003-P and CardiolRx.
How each study uses Cannabidiol is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Cannabidiol studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 25 Jun 2018 · EPIDIOLEX · NDA 210365 (FDA, Drugs@FDA)
- European Union
- 19 Sept 2019 · Epidyolex · EMEA/H/C/004675 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Other names
- CBD
- 92
Studies by the year they started
313 studies that test it; most in 2021 (45); 3 more planned to start later
| Year | Studies |
|---|---|
| 2002 | 1 |
| 2009 | 1 |
| 2010 | 4 |
| 2011 | 2 |
| 2012 | 4 |
| 2013 | 3 |
| 2014 | 10 |
| 2015 | 13 |
| 2016 | 15 |
| 2017 | 9 |
| 2018 | 12 |
| 2019 | 17 |
| 2020 | 30 |
| 2021 | 45 |
| 2022 | 41 |
| 2023 | 25 |
| 2024 | 28 |
| 2025 | 27 |
| 2026 | 26 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 69 · Other 247
Jazz Pharmaceuticals (27) · University of Colorado, Denver (10) · Johns Hopkins University (10) · University of California, San Diego (8) · Central Institute of Mental Health, Mannheim (8) · Yale University (7) · NYU Langone Health (7) · University of California, Los Angeles (6)
Often tested with
Tested in the same studies.
Dronabinol (30) · Cannabinol (2) · Clobazam (2) · Nabiximols (2) · Proteasomal Ubiquitin Receptor ADRM1 (1) · Citalopram (1) · Morphine (1) · Cannabidivarin (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 40, 10 in phase 3
Studies that test Cannabidiol, phase 3 first.
- Dec 2026Effects of Cannabidiol (CBD) Versus Placebo as an Adjunct to Treatment in Early PsychosisPhase 3 · University of California, San Diego
- Apr 2027Study of Cannabidiol in Sanfilippo SyndromePhase 2/3 · Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
- Apr 2027Alcohol Use Disorder and CannabidiolPhase 2/3 · University of Colorado, Denver
- May 2027Study Assessing the Efficacy and Safety of cANnabidiol Oral Solution for Joint Pain of Adjuvant enDOcrine theRApy in Patients With Early Breast CancerPhase 3 · Gustave Roussy, Cancer Campus, Grand Paris
- Jun 2027Safety and Efficacy of Oral Cannabis in Chronic Spine PainPhase 3 · University of Colorado, Denver
- Jul 2027Adjunctive Cannabidiol for Recovery From Opioid StudyPhase 3 · Icahn School of Medicine at Mount Sinai
- Aug 2027Cannabidiol-Assisted Learning for Managing Generalized Anxiety DisorderPhase 3 · Wayne State University
- Sep 2027Cannabidiol (CBD) in Pain Reduction for Knee OsteoarthritisPhase 2/3 · NYU Langone Health
- Sep 2027Evaluating Efficacy and Safety of CBD TPM Capsules for Use in InsomniaPhase 3 · Avecho Biotechnology
- Nov 2027Cannabidiol as add-on Therapy for Children With Refractory Epilepsy (CBD-uN1que), a High-quality Individualized Approach: a Series of N-of-1 TrialsPhase 3 · UMC Utrecht
Studies
Open first, then newest update. How each study uses Cannabidiol is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 316
- Cannabidiol (CBD) in Adults With ASDRecruitingPhase 1Johns Hopkins UniversityNCT05015439Written as Cannabidiol
- Cannabidiol as an Adjunct Treatment for Alcohol Withdrawal and CravingRecruitingPhase 2/3Johns Hopkins UniversityNCT07148843Written as Cannabidiol (CBD)
- Effects of Cannabidiol on Memory and Attention in Adults Aged 60-70: A Pilot StudyNot yet recruitingNot applicableMedical University of SilesiaNCT07910292Written as Cannabidiol (CBD)
- Neuroprotective Potential of Cannabidiol (CBD) in Preventing Oxaliplatin (Ox)-Induced NeuropathyRecruitingEarly Phase 1Fox Chase Cancer CenterNCT07167446Written as Cannabidiol (CBD)
- A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset SeizuresRecruitingPhase 1Jazz PharmaceuticalsNCT07233239Written as CBD-OS
- A Study to Investigate the Effect of Gradual Titration to Optimize Cannabidiol Treatment in Adults With LGSNot yet recruitingPhase 4Jazz PharmaceuticalsNCT07728097Written as Cannabidiol Oral Solution
- Cannabidiol-Assisted Learning for Managing Generalized Anxiety DisorderRecruitingPhase 3Wayne State UniversityNCT07123467Written as Low-Dose Cannabidiol
- Cannabidiol in Opioid Use Disorder and Chronic Pain With BuprenorphineRecruitingEarly Phase 1Yale UniversityNCT07886606Written as 400 mg Cannabidiol
- Stratification and Treatment in Early Psychosis Study -ASSISTNot yet recruitingPhase 3University of OxfordNCT07326124Written as CBD 100 mg/mL Oral Solution
- Stratification and Treatment in Early Psychosis Study - PROMOTENot yet recruitingPhase 3University of OxfordNCT07434973Written as Cannabidiol (CBD)
- Stratification and Treatment in Early Psychosis Study - ENHANCERecruitingPhase 3University of OxfordNCT06778564Written as CBD 100 mg/mL Oral Solution
- The Effects of Cannabidiol on the Driving Performance of Healthy Adults by Dose and SexRecruitingPhase 1West Virginia UniversityNCT06686914Written as Cannabidiol (CBD) Oil 300mg
- Epidiolex Trial for Presymptomatic Treatment of Sturge-Weber SyndromeRecruitingPhase 2Johns Hopkins UniversityNCT07778810Written as Epidiolex 100 mg/mL Oral Solution
- Adjunctive Cannabidiol for Recovery From Opioid StudyRecruitingPhase 3Icahn School of Medicine at Mount SinaiNCT06940674Written as Cannabidiol
- CBD for Breast Cancer Primary TumorsRecruitingPhase 1Medical University of South CarolinaNCT06148038Written as CBD Oral
- Safety and Efficacy of Cannabidiol (CBD) for Symptoms of PTSD in AdultsRecruitingPhase 2University of NebraskaNCT05269459Written as Cannabidiol Administered as Nantheia ATL5
- CBD for Lower Urinary Tract Dysfunction in Spinal Cord InjuryRecruitingPhase 2University of Wisconsin, MadisonNCT06840899Written as CBD
- Cannabidiol for Pain Relief of Patients With End-stage mCRPCRecruitingPhase 2Regionshospital NordjyllandNCT07549256Written as Cannabidiol
- Cannabidiol and Alcohol Use Disorder PhenotypesRecruitingPhase 2University of Colorado, DenverNCT07279558Written as Full-Spectrum Cannabidiol (CBD)
- Cannabis (THC vs. CBD) in Multiple SclerosisRecruitingPhase 2University of CalgaryNCT06261489Written as CBD
See all 316 studies that test Cannabidiol →
Given beside what is tested · 5 — Cannabidiol is usual care or a partner of the new treatment
- Effects of a Hemp Product on the Pharmacokinetics and Pharmacodynamics of ClopidogrelRecruitingEarly Phase 1Washington State UniversityNCT06692933Written as Cannabidiol in the form of hemp
- Effects of CBD/CBD-A Oral Extract on Resting-state EEG and Neuropathic Pain Symptoms After SCICompletedPhase 1/2University of MiamiNCT05630235Written as CBD/CBD-A
- The Pharmacodynamics of Cannabinoid-Caffeine CombinationsCompletedEarly Phase 1Johns Hopkins UniversityNCT05478863Written as Oral CBD
- Study of the Glutaminase Inhibitor CB-839 in Solid TumorsCompletedPhase 1Calithera Biosciences, IncNCT02071862Written as CBD
- Reducing the Harmful Effects of Cannabis Use: Finding the Optimal CBD:THC RatioCompletedNot applicableKing's College LondonNCT05170217Written as Cannabidiol
As the comparator · 5 — what is tested is compared with Cannabidiol
- Challenging the Endocannabinoid System in Sleep Restricted Healthy Volunteers to Modulate Physiological Arousal (CANISLEEP) StudyRecruitingNot applicableKing's College LondonNCT07656350Written as CBD
- SCI-210 in the Treatment of Children and Young Adults With AutismEvaluate the Safety, Tolerability and Efficacy of SCI-210 in Children With Autism Spectrum Disorder (ASD)RecruitingNot applicableSciSparcNCT05182697Written as Oral CBD oil
- Safety and Effect on Pain and Function According to RAPID-3 of IHL-675A in Patients With Rheumatoid ArthritisTerminatedPhase 2Incannex Healthcare LtdNCT05942911Written as Cannabidiol
- Pharmacokinetic Study of a Novel Cannabidiol (CBD) Formulation in Healthy VolunteersCompletedPhase 1NW PharmaTech LtdNCT07186283Written as Epidyolex
- Comparative PK Study Of THC/CBD FormulationsStatus unknownPhase 1CapSoilNCT06149988Written as THC/CBD oil
What changed recently
From the registry's own updates since Oct 18, 2026.
Results posted2
- Mechanisms of CBD for Chronic PainOct 29, 2026NCT04044729
- Cannabidiol and Prolonged ExposureOct 28, 2026NCT03518801
Newly registered2
- Effects of Cannabidiol on Memory and Attention in Adults Aged 60-70: A Pilot StudyNov 2, 2026NCT07910292
- Cannabidiol in Opioid Use Disorder and Chronic Pain With BuprenorphineOct 21, 2026NCT07886606
Codes
What other systems call Cannabidiol · ClinicalTrials.gg INT007129
- MeSH (NLM) D002185CannabidiolConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 19GBJ60SN5CANNABIDIOLConfirmed FDA, NLM, Wikidata
- RxNorm 2045371Confirmed FDA, Wikidata
- Wikidata Q422917cannabidiolConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C118452CannabidiolOne source FDA
- DrugBank DB09061One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D002185 | Cannabidiol | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 19GBJ60SN5 | CANNABIDIOL | Confirmed FDA, NLM, Wikidata |
| RxNorm | 2045371 | — | Confirmed FDA, Wikidata |
| Wikidata | Q422917 | cannabidiol | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C118452 | Cannabidiol | One source FDA |
| DrugBank | DB09061 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.